A Phase 1 Study of Cizutamig in IgE Mediated Diseases

Clinical trial NCT07408869 · WITHDRAWN

Trial details

NCT number: NCT07408869
Sponsor: Candid Therapeutics
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

IgE-Mediated Hypersensitivity IgE Mediated Food Allergy IgE-Mediated Cow Milk Allergy

Start date: 2026-04-01
Primary completion: 2026-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.